T Cells Plus Selected Use of Blinatumomab
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 52 patients (estimated)
- Sponsors
- St. Jude Children's Research Center
- Tags
- Allogeneic Stem Cell Transplant, Bispecific Antibody, CD19
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1648
- NCT Identifier
- NCT02790515
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.